AI assistant
Sending…
Avantor, Inc. — Director's Dealing 2023
Mar 6, 2023
30731_dirs_2023-03-06_a3ad28b9-c911-4955-bd50-aa952312a298.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Avantor, Inc. (AVTR)
CIK: 0001722482
Period of Report: 2023-03-03
Reporting Person: Brophy Gerard (EVP, Biopharma Production)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-03 | Common Stock | S | 3914 | $25 | Disposed | 108715 | Direct |
Footnotes
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
More from Avantor, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 1
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Feb 25